• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Wolters Kluwer Health

Anonymous board for Wolters Kluwer Health
Replies
0
Views
3K
anonymous
Replies
11
Views
12K
Anonymous
Replies
2
Views
4K
Anonymous
Replies
1
Views
3K
Anonymous
Replies
8
Views
5K
Anonymous
Replies
34
Views
18K
Anonymous